[Other] Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes

vsp_ree Post time The day before yesterday 11:59 | Show all posts |Read mode
Reward20points

The Lancet
https://doi.org/10.1016/S0140-6736(23)01053-X

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
[size=1.38]


Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply2 Show all posts
shiroshiro Post time The day before yesterday 11:59 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

vsp_ree Post time The day before yesterday 12:08 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    240

Latest Reply

Return to the list